Director/PDMR Shareholding

April 26, 2022

The Company has received notification from Vulpes Investment Management Pte Ltd ("Vulpes") that on 22 April 2022 it purchased 183,812 ordinary shares of 1p in the capital of the Company ("Ordinary Shares") at a price of 4p per Ordinary Share (the “Purchase”). Following the Purchase, Vulpes has a total direct and indirect interest in 67,475,006 Ordinary Shares, equivalent to 22.86% of Proteome Sciences' total issued share capital.


Back to News